They know what their doing..downgrade so they can keep low and have their Hapmton buddies buy cheap:..same ploy as Goldman..S..legal corruption..
I still laugh at the dumb dumb shorts for the last 2 decades..go gildzilla!!! :-)
An Anthem spokesman declined to comment on the lawsuits, specifically, but he did write us that “the newer hepatitis C drugs have been approved through the FDA breakthrough therapy process and tested in fewer people than typical clinical trials, which means our knowledge is more limited on these drugs.
Hey Cat..How about Goldman Sachs too?? don't they have a $84 target??? :-)
By JUSTIN BAER and JOE LIGHT
Updated Aug. 22, 2014 6:11 p.m. ET
Goldman Sachs Group Inc. settled a U.S. housing regulator's lawsuit for about $1.2 billion, resolving claims the Wall Street firm failed to disclose the risks on the mortgage bonds it sold before the financial crisis.